Table 4.
Demographics, treatment metrics and outcomes in patients over the age of 65 years, comparing those who underwent surgical intervention or not
| Not operated (N = 115) | Operated (N = 70) | Total (N = 185) | p value | |
|---|---|---|---|---|
| Age, years, mean (SD) | 81 (8) | 75 (7) | 79 (8.0) | < 0.001 |
| Sex, Female n (%) | 66 (57.4%) | 25 (35.7%) | 91 (49.2%) | 0.004 |
| Charlson Comorbidity Index, median (IQR) | 5.0 (4.0–6.2) | 4.0 (3.0–5.0) | 4.0 (4.0–6.0) | 0.031 |
| Age-adjusted Charlson Comorbidity Index, median (IQR) | 8.0 (7.0–10.0) | 8.0 (6.0–9.0) | 8.0 (7.0–10.0) | 0.024 |
| BMI (kg/m2), mean (SD) | 27.0 (5.6) | 28.6 (5.3) | 27.6 (5.5) | 0.0491 |
| ASA, n (%) | 0.1972 | |||
| 1 | 1 (3.1%) | 4 (7.7%) | 5 (6.0%) | |
| 2 | 8 (25.0%) | 23 (44.2%) | 31 (36.9%) | |
| 3 | 17 (53.1%) | 19 (36.5%) | 36 (42.9%) | |
| 4 | 6 (18.8%) | 6 (11.5%) | 12 (14.3%) | |
| Diagnosis, n (%) | < 0.0011 | |||
| Cholecystitis | 34 (29.6%) | 52 (74.3%) | 86 (46.5%) | |
| Gallstone pancreatitis | 27 (23.5%) | 4 (5.7%) | 31 (16.8%) | |
| Cholangitis | 26 (22.6%) | 5 (7.1%) | 31 (16.8%) | |
| CBD stone | 27 (23.5%) | 9 (12.9%) | 36 (19.5%) | |
| Mirizzi syndrome or bilioenteric fistula | 1 (0.9%) | 0 (0.0%) | 1 (0.5%) | |
| AAST Cholecystitis Grade, n (%) | 0.6421 | |||
| 1 | 0 (0%) | 0 (0%) | 0 (0%) | |
| 2 | 26 (76.5%) | 40 (76.9%) | 66 (76.7%) | |
| 3 | 7 (20.6%) | 8 (15.4%) | 15 (17.4%) | |
| 4 | 1 (2.9%) | 2 (3.8%) | 3 (3.5%) | |
| 5 | 0 (0.0%) | 2 (3.8%) | 2 (2.3%) | |
| Grade 3 or higher | 8.0 (23.5%) | 12.0 (23.1%) | 20.0 (23.3%) | 0.9611 |
| AAST Pancreatitis Grade, n (%) | 0.7001 | |||
| 1 | 23 (85.2%) | 3 (75.0%) | 26 (83.9%) | |
| 2 | 3 (11.1%) | 1 (25.0%) | 4 (12.9%) | |
| 3 | 1 (3.7%) | 0 (0.0%) | 1 (3.2%) | |
| 4 | 0 (0%) | 0 (0%) | 0 (0%) |
1Linear Model ANOVA 2Trend test for ordinal variables